Tony Bruns

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 184 publications

Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial.

Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial.

Journal: BMJ open

Published: August 12, 2026

Letter: Attempted Validation of Villin-1 as a Gut Barrier Marker in Decompensated Cirrhosis-Potential Confounding by Tubular Injury and Aetiology.

Letter: Attempted Validation of Villin-1 as a Gut Barrier Marker in Decompensated Cirrhosis-Potential Confounding by Tubular Injury and Aetiology.

Journal: Alimentary pharmacology & therapeutics

Published: March 07, 2026

Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascites.

Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascites.

Journal: JHEP reports : innovation in hepatology

Published: March 05, 2026

Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation.

Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation.

Journal: Gut microbes

Published: February 21, 2026

Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter study.

Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter study.

Journal: JHEP reports : innovation in hepatology

Published: December 09, 2025

Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-study.

Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-study.

Journal: Hepatology international

Published: November 14, 2025

Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults

Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults

Journal: Zeitschrift fur Gastroenterologie

Published: November 10, 2025

The future of hepatology: Preventing liver disease together with the public, scientists and artificial intelligence.

The future of hepatology: Preventing liver disease together with the public, scientists and artificial intelligence.

Journal: JHEP reports : innovation in hepatology

Published: October 01, 2025

Peritoneal immunity in decompensated cirrhosis.

Peritoneal immunity in decompensated cirrhosis.

Journal: Expert review of clinical immunology

Published: September 29, 2025

Outbreak of multi-drug resistant Vibrio cholerae Ogawa Serotype in Ibb, Yemen (2018-2024): The OVCO-IY study.

Outbreak of multi-drug resistant Vibrio cholerae Ogawa Serotype in Ibb, Yemen (2018-2024): The OVCO-IY study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 25, 2025

Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study.

Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study.

Journal: Cancer discovery

Published: July 30, 2025

Acute Variceal Bleeding During the SARS-CoV-2 Pandemic: A National Multicenter Observational Study.

Acute Variceal Bleeding During the SARS-CoV-2 Pandemic: A National Multicenter Observational Study.

Journal: Journal of clinical medicine

Published: July 23, 2025

Showing 1-12 of 184

Last Updated: 09/26/2026